European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)

por Shovlin, Claire L., Buscarini, Elisabetta, Kjeldsen, Anette D., Mager, Hans Jurgen, Sabba, Carlo, Droege, Freya, Geisthoff, Urban, Ugolini, Sara, Dupuis-Girod, Sophie
Publicado 2018

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia

por Buscarini, Elisabetta, Botella, Luisa Maria, Geisthoff, Urban, Kjeldsen, Anette D., Mager, Hans Jurgen, Pagella, Fabio, Suppressa, Patrizia, Zarrabeitia, Roberto, Dupuis-Girod, Sophie, Shovlin, Claire L.
Publicado 2019

Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1

por Galaris, Georgios, Montagne, Kévin, Thalgott, Jérémy H., Goujon, Geoffroy J. P. E., van den Driesche, Sander, Martin, Sabrina, Mager, Hans-Jurgen J., Mummery, Christine L., Rabelink, Ton J., Lebrin, Franck
Publicado 2021

BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice

por Bakker, Wineke, Dingenouts, Calinda K. E., Lodder, Kirsten, Wiesmeijer, Karien C., de Jong, Alwin, Kurakula, Kondababu, Mager, Hans-Jurgen J., Smits, Anke M., de Vries, Margreet R., Quax, Paul H. A., Goumans, Marie José T. H.
Publicado 2021

The evolution of survival of pulmonary arterial hypertension over 15 years

por Hendriks, Paul M., Staal, Diederik P., van de Groep, Liza D., van den Toorn, Leon M., Chandoesing, Prewesh P., Kauling, Robert M., Mager, Hans‐Jurgen, van den Bosch, Annemien E., Post, Marco C., Boomars, Karin A.
Publicado 2022

Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip

por Orlova, Valeria V., Nahon, Dennis M., Cochrane, Amy, Cao, Xu, Freund, Christian, van den Hil, Francijna, Westermann, Cornelius J.J., Snijder, Repke J., Ploos van Amstel, Johannes Kristian, ten Dijke, Peter, Lebrin, Franck, Mager, Hans-Jurgen, Mummery, Christine L.
Publicado 2022

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)

por Eker, Omer F., Boccardi, Edoardo, Sure, Ulrich, Patel, Maneesh C., Alicante, Saverio, Alsafi, Ali, Coote, Nicola, Droege, Freya, Dupuis, Olivier, Fialla, Annette Dam, Jones, Bryony, Kariholu, Ujwal, Kjeldsen, Anette D., Lefroy, David, Lenato, Gennaro M., Mager, Hans Jurgen, Manfredi, Guido, Nielsen, Troels H., Pagella, Fabio, Post, Marco C., Rennie, Catherine, Sabbà, Carlo, Suppressa, Patrizia, Toerring, Pernille M., Ugolini, Sara, Buscarini, Elisabetta, Dupuis-Girod, Sophie, Shovlin, Claire L.
Publicado 2020